Articles by Cynthia Challener, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Cynthia Challener, PhD

Ensuring the Safety, Quality, and Identity of Biopharmaceutical Raw Materials

Going beyond pharmacopeial requirements is essential for the quality and safety of raw materials.
Aug 1, 2014

Going beyond pharmacopeial requirements is essential for the quality and safety of raw materials.

Analyzing Proteins Using SEC, MALS, and UHPLC

Light scattering analysis combined with more rapid size exclusion chromatography improves protein characterization.
Jul 1, 2014

Light scattering analysis combined with more rapid size exclusion chromatography improves protein characterization.

Assuring Equivalency of Alternative Lot-Release Test Methods

New test methods can provide improved quality and efficiency, but they must be validated to demonstrate equivalency.
Jun 1, 2014

New test methods can provide improved quality and efficiency, but they must be validated to demonstrate equivalency.

Biopharma Moves to Integrated, Single-Use, Downstream Processing

Suppliers see challenges to the adoption of single-use technologies for downstream processing as opportunities.
Jun 1, 2014

Suppliers see challenges to the adoption of single-use technologies for downstream processing as opportunities.

A Sampling of New Tools for Downstream Processing

Industry suppliers describe new technologies to facilitate downstream processing.
Jun 1, 2014

Industry suppliers describe new technologies to facilitate downstream processing.

Novel Vaccine Technologies Meet the Need for Pandemic and Therapeutic Solutions

New approaches to vaccine production are targeting rapid supply for pandemic situations and broadly effective therapeutic treatments.
May 1, 2014

New approaches to vaccine production are targeting rapid supply for pandemic situations and broadly effective therapeutic treatments.

Improving Protein Expression with Novel Systems

New human and plant-based expressions systems can enable faster product development and improve quality at potentially lower costs.
May 1, 2014

New human and plant-based expressions systems can enable faster product development and improve quality at potentially lower costs.

Monoclonal Antibodies Key to Unlocking the Biosimilars Market

The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth.
Apr 1, 2014

The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth.

Advances in Linker Technology

The targeted delivery of cytotoxic drugs using antibody drug conjugates would not be possible without effective linkers to connect and then release the key chemical and biological materials.
Mar 1, 2014

The targeted delivery of cytotoxic drugs using antibody drug conjugates would not be possible without effective linkers to connect and then release the key chemical and biological materials.

ADVERTISEMENT

ADVERTISEMENT

Click here